Login / Signup

Treatment choice, satisfaction and quality of life in patients with Graves' disease.

Helen M ConaglenJade A U TamateaJohn V ConaglenMarianne S Elston
Published in: Clinical endocrinology (2018)
Patient satisfaction with therapy and QoL does not differ by treatment type. Therefore, clinical and social factors, in combination with patient choice and resource availability, should determine which treatment modality patients with Graves' disease should receive.
Keyphrases
  • patient satisfaction
  • healthcare
  • mental health
  • replacement therapy
  • mesenchymal stem cells